Adrian Kilcoyne is Chief Medical Officer of Celularity Inc. Currently has a direct ownership of 1.12 Million shares of CELU, which is worth approximately $2.56 Million. The most recent transaction as insider was on Feb 17, 2024, when has been sold 52,762 shares (Class A Common Stock) at a price of $0.43 per share, resulting in proceeds of $22,687. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.12M
0% 3M change
4.49% 12M change
Total Value Held $2.56 Million

Adrian Kilcoyne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2024
SELL
Payment of exercise price or tax liability
$22,687 $0.43 p/Share
52,762 Reduced 4.49%
1,122,238 Class A Common Stock
Jul 14 2023
BUY
Grant, award, or other acquisition
-
875,000 Added 42.68%
1,175,000 Class A Common Stock
Feb 17 2023
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Class A Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
AK

Adrian Kilcoyne

Chief Medical Officer
Short Hills, NJ

Track Institutional and Insider Activities on CELU

Follow Celularity Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CELU shares.

Notify only if

Insider Trading

Get notified when an Celularity Inc insider buys or sells CELU shares.

Notify only if

News

Receive news related to Celularity Inc

Track Activities on CELU